"There will be no investments in research and the quality of medicines will be affected," said BS Ajai Kumar, CEO of Healthcare Global Enterprises.from Moneycontrol Business News https://ift.tt/2tHYO9Z
"There will be no investments in research and the quality of medicines will be affected," said BS Ajai Kumar, CEO of Healthcare Global Enterprises.
Comments
Post a Comment